Synthesize Bio’s generative genomics models predict the results of gene expression experiments with unprecedented accuracy Funding led by Madrona with participation from AI2 Incubator, Sahsen Ventures, Inner Loop Capital and Point Field Partners Synthesize Bio is actively engaging with biopharma partners to enable more confident drug development decisions using generative genomics GEM-1 foundation model now […]
The additions enhance Cell Q’s capabilities to scale high-throughput sample prep, liquid-handling verification, COI/COC preservation, full-spectrum flow cytometry, and synthetic controls in Cell Q. The first performance data from the Cell Q, an automated QC platform purpose-built to match the throughput of the Cell Shuttle™, will be presented at the 10th CAR-TCR Summit on September […]
South San Francisco, CA, USA – Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announces multiple strategic technology partnerships to advance the Cell Q™, the first fully automated quality control testing platform purpose-built to match the commercial-scale throughput for cell therapy manufacturing. Cellares is unveiling these partnerships ahead of the 10th Annual CAR-TCR Summit, […]
LIVERMORE, Calif. — Today, Precision Cell Systems (PCS) announced its official launch following the strategic acquisitions of S2 Genomics and ORFLO, creating a unified company that addresses critical bottlenecks in cell analysis workflows. PCS launches with significant market traction: over 1,000 installed instruments, more than 700 active customers, and a technology portfolio validated by over 500 […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke’s Hospital of the University of Cambridge, United Kingdom. Together with its comprehensive menu of assays for DNA, RNA, and protein […]
Tempe, AZ — Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR microscopy technology first launched in 2017, the SPRm 220 brings enhanced throughput, improved usability, and unmatched capability in label-free, cell-based kinetic analysis. Designed specifically for the challenges of membrane protein research, […]
Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has announced the launch of its Microbial Amplicon Barcoding Kit 24 V14, to enable faster and more flexible microbial analysis in a single workflow. Oxford Nanopore’s new kit has been optimised to provide an information-rich, rapid, and accessible full-length amplicon […]
RiboMarker-NextGen Biomarker Discovery SANTA CRUZ, CA, UNITED STATES — RealSeq Biosciences, a pioneer in RNA-based diagnostics, today announced it has received a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) (FAIN# R44HG013284; Federal Award Date: August 15, 2025). This highly competitive award provides multi-year, non-dilutive funding to accelerate […]
New formats redefine molecular assay development by cutting refrigeration costs, simplifying logistics, and ensuring uncompromised performance at room temperature. CINCINNATI — The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of the industry’s first liquid qPCR master mixes proven stable for over […]
The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders’ meeting. Maria Rankka succeeds Rolf Classon who, for health reasons, has chosen to resign from his position on the board and as […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
